SeqWright last week said it won a large-scale contract from the US Department of Agriculture to sequence 1,000 influenza virus genomes.
But the company, which prides itself as an early adopter of emerging DNA analysis tools, believes the time is not quite right for bringing next-generation sequencing in-house for this or other projects — particularly for producing sequencing data that meet US Food and Drug Administration standards, a special focus of the firm.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.